Tech Company Financing Transactions
Cellerant Therapeutics Funding Round
Allen & Company and MPM Capital invested in a $16 million Series B funding round for Cellerant Therapeutics. The funding round was announced on 5/11/2005.
Transaction Overview
Company Name
Announced On
5/11/2005
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds from this financing will be used to accelerate commercial development of our HSC purification platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1561 Industrial Rd.
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
Cellerant Therapeutics is a biotechnology company offering products for the regulation of the hematopoietic system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ram Mandalam
Chief Financial Officer
Rodney Young
Browse more venture capital transactions:
Prev: 5/10/2005: Vantage Oncology venture capital transaction
Next: 5/11/2005: Anacor Pharmaceuticals venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs